Ortoma Q4’2024: Continued strong progress at year-end - Redeye

Redeye makes some revisions based on the Q4 report. The milestones did not arrive as expected in the quarter; however, the sales based on the DePuy agreement yielded better results. The milestones will come; we see this as a timing issue. We have pushed our milestone expectation to arrive in 2025e as the level was lower in the quarter. The progress continues, with a lot of positives to come during 2025e. With the rolling over to a new year and a slight WACC change, our fair value range and the Base case increases to SEK 23 (20) per share. Following this report, we also change the lead analyst.

Länk till analysen i sin helhet: https://www.redeye.se/research/1084504/ortoma-q42024-continued-strong-progress-at-year-end?utm_source=finwire&utm_medium=RSS